CSL300_2301_Ph3 is intended for collecting patient outcomes for clinical trials.
The CSL Behring CSL300_2301 Phase 3 App is intended for use to collect patient reported outcomes relating to the CSL300_2301 Phase 3 clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
The REIMAGINE 4 NN9388-4894 Study App will collect information such as doses...
Janssen eCOA App is intended for use to collect participant reported outcomes...
Reata eCOA App is intended for use to collect patient reported outcomes...
ICON P1-COPD-04-INT eCOA App is intended for use to collect patient reported...
The REIMAGINE 2 NN9388-4896 Study App will collect information such as doses...
15-06 eCOA App is intended for use to collect patient reported outcomes...
Created with AppPage.net
Similar Apps - visible in preview.